You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: Therapy-orienting testing of EGFR inhibitor-resistant non-small cell lung cancer

€3.03

SKU: product-article-10990 Category: General

Description
Reviews (0)

Description

Therapy-orienting testing of EGFR inhibitor-resistant non-small cell lung cancer

Reviews

There are no reviews yet.

Be the first to review “Article: Therapy-orienting testing of EGFR inhibitor-resistant non-small cell lung cancer”

You must be logged in to post a review.

Top

Article: Therapy-orienting testing of EGFR inhibitor-resistant non-small cell lung cancer

Description

Reviews

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in melanoma

Article: Calendar of events

Article: Highlights in squamous cell carcinoma of the head and neck